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Background: Vitamins and carotenoids are key micronutrients facilitating the maintenance of health, as evidenced by
the increased risk of disease with low intake. Optimal phenotypic flexibility, i.e., the ability to respond to a physiological
challenge, is an essential indicator of health status. Therefore, health can be measured by applying a challenge test and
monitoring the response of relevant phenotypic processes. In this study, we assessed the correlation of three fat-soluble
vitamins, (i.e., vitamin A or retinol, vitamin D3, two homologues of vitamin E) and four carotenoids (i.e., α-carotene,
β-carotene, β-cryptoxanthin, and lycopene), with characteristics of metabolic and inflammatory parameters at baseline
and in response to a nutritional challenge test (NCT) in a group of 36 overweight and obese male subjects, using
proteomics and metabolomics platforms. The phenotypic flexibility concept implies that health can be measured by the
ability to adapt to a NCT, which may offer a more sensitive way to assess changes in health status of healthy subjects.
Results: Correlation analyses of results after overnight fasting revealed a rather evenly distributed network in a number
of relatively strong correlations per micronutrient, with minor overlap between correlation profiles of each compound.
Correlation analyses of challenge response profiles for metabolite and protein parameters with micronutrient status
revealed a network that is more skewed towards α-carotene and γ-tocopherol suggesting a more prominent role for
these micronutrients in the maintenance of phenotypic flexibility. Comparison of the networks revealed that there is
merely overlap of two parameters (inositol and oleic acid (C18:1)) affirming that there is a specific biomarker response
profile upon NCT.
Conclusions: Our study shows that applying the challenge test concept is able to reveal previously unidentified
correlations between specific micronutrients and health-related processes, with potential relevance for maintenance of
health that were not observed by correlating homeostatic measurements. This approach will contribute to insights on
the influence of micronutrients on health and help to create efficient micronutrient intervention programs.
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Vitamins are defined as organic substances that cannot
or can only be partially synthesized by the body for the
maintenance of health and well-being throughout every
stage of life from conception to old age [1]. Many micro-
nutrients, including the A and E vitamins, are involved
in the homeostatic regulation of physiological processes
intimately involved in whole body metabolism, including
oxidative-reductive and inflammatory pathways [2]. Ca-
rotenoids are a class of natural, fat-soluble pigments
found principally in plants. They have potential antioxi-
dant properties because of their chemical structure and
interaction with biological membranes [3]. Chronic in-
sufficiencies in micronutrients including vitamins may
contribute to risks of poor growth, cognitive develop-
ment, morbidity, and mortality [4, 5]. Over the past cen-
tury, our understanding of the role of nutrition,
including that of vitamins, in relation to health has made
tremendous progress. This was primarily achieved by a
combination of epidemiological studies assessing micro-
nutrient intake and in vitro and in vivo experiments fo-
cusing on single targets or pathways affected by single
micronutrients. As a result, significant improvements
have been made in meeting the needs of undernourished
populations for vitamins and other micronutrients
resulting in increased intake and the associated improve-
ments in health [6].
To elevate the level of understanding in the science of
micronutrient biology and thereby the caliber of inter-
vention programs targeting the undernourished popula-
tions, the nutrition field faces major challenges. The first
is to establish relevant status biomarkers for micronu-
trient use in epidemiological studies and intervention
studies [7]. For many micronutrients, biochemical as-
sessment of plasma concentrations is of limited value
due to strict homeostatic regulation of circulating micro-
nutrient levels and/or large body stores that are not
reflected by circulating concentrations. Therefore, there
is a clear need for reliable biomarkers that provide a true
understanding of biochemical processes intimately
linked to micronutrients statuses, e.g., transport or en-
zyme activities.
Secondly, our current knowledge of micronutrient
biology is largely based on the classic definition of health
as “a state of complete physical, mental and social well-
being and not merely the absence of disease and infirm-
ity” [8]. This definition is in line with much of the
nutritional research measuring and correlating states in
observational studies or shifting states in intervention
studies. Recently, experts in the field have adapted the
definition of health to the ability to adapt and self-
manage in the face of social, physical, and emotional
challenges such as infections, metabolic stress, and men-
tal stress [9, 10]. In this regard, it is important to assesshealth not only by static measurements but also as the
ability to respond in a healthy, resilient manner to rele-
vant challenges, or in other words, to measure “pheno-
typic flexibility” [11, 12]. By default, this means that
health effects of interventions should be assessed not
only by shifting states but also in modulation of chal-
lenge responses towards a more healthy physiological re-
sponse. In recent years, it has become clear that
perturbation of homeostasis by using nutritional chal-
lenge tests (NCT) is informative to quantify health, its
related processes, and how this is influenced by food
and nutrition [13–16]. Optimal phenotypic flexibility is
driven by a well-orchestrated physiological machinery
allowing the organism to adapt to the continuously
changing environment, of which food plays a major role.
Processes and mechanisms forming the basis of pheno-
typic flexibility include substrate fluxes for ATP produc-
tion and biosynthesis, oxidative stress and inflammatory
responses, and immune functions as well as DNA repair,
apoptosis, etc. [12]. Inadequate functioning of these pro-
cesses reduces the resilience to daily challenges, culmin-
ating in the onset and/or further development of disease.
Micronutrients including those assessed in this study are
expected to play a key role in the regulation of pheno-
typic flexibility by facilitating adequate responses to
stressors and maintenance of homeostasis [2, 17].
To address the abovementioned challenges in the field
of micronutrients, a comprehensive systems nutrition
approach has often been proposed [18–23], but to our
knowledge, only two studies applying proteomics and/or
metabolomics have been published so far [7, 17]. This
systems nutrition study is the first to provide in-depth
insights into the complexity of correlations of micronu-
trient status with molecular processes underpinning
health based on both static and NCT response data.
Plasma status of eight micronutrients has been mea-
sured in a group of 36 healthy but overweight or obese
male individuals [14, 24]. The concentrations of caroten-
oids (α-carotene, β-carotene, β-cryptoxanthin, and
lycopene), retinol, α- and γ-tocopherol, and 25-
hydroxyvitamin D3 have been integrated with a total of
153 plasma metabolites, 7 clinical chemistry measures,
79 plasma proteins, and an additional 1150 proteins
quantified via SOMAscan after overnight fasting, and in
response to a NCT. The results clearly demonstrated
that nutritional challenge response analysis results in a
differential association of multiple micronutrients with
health-related processes as compared to static analysis
based on overnight fasting measures.
Methods
Study design, execution, and analysis
The execution and analytical methodologies of the nutri-
tional intervention study, including the postprandial
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detail [14, 24]. In short, 36 healthy overweight and obese
men (BMI 25.6–34.7 kg/m2) with mildly elevated C-
reactive protein (CRP) levels (1.0–8.1 mg/L) with the
aim to focus on low-grade chronic inflammation instead
of acute inflammation were included in a double-blind,
placebo-controlled, crossover study with test treatment
periods of 5 weeks to assess the effects of an anti-
inflammatory dietary mixture (resveratrol, green tea ex-
tract, a-tocopherol, vitamin C, n-3 (omega-3) polyunsat-
urated fatty acids, and tomato extract provided in hard
and soft gel capsules). For the purpose of this paper, we
only included the placebo data in subsequent analysis.
Placebo hard and soft gel capsules contained 365 mg
microcrystalline cellulose (Microz Food Supplements)
and 1360 mg soy lecithin (soya lecithin; Solgar Vitamin
and Herb), respectively. At the end of each test period, a
NCT, i.e., 500 ml dairy shake (fat 58.7 E%), comprising
300 ml custard, 150 ml cream cheese, and 50 ml whip-
ping cream, was ingested after a standardized fasting
protocol (Additional file 1: Table S1 [14]). After an over-
night fast, the subjects received a light standardized
breakfast. After at least a 4-h fast (except water), they
were offered the dairy shake. At time points 0 (fasting
condition), 30, 60, 120, 180, 240, and 360 min after the
dairy shake, plasma samples were collected and were
stored at −80 °C until further use. The study was per-
formed according to the International Conference on
Harmonization of Technical Requirements for Registra-
tion of Pharmaceuticals for Human Use; guidelines for
Good Clinical Practice; the Helsinki Declaration of 1975,
as revised in 2000; and the Dutch Regulations on Med-
ical Research involving Human Subjects (WMO, 1999 as
revised in 2000). The study protocol had been approved
by the independent Medical Ethics Committee METOPP
located in Tilburg, The Netherlands. The study was
conducted between December 2006 and June 2007 and
was registered on ClinicalTrials.gov with identifier:
NCT00655798. Detailed description of methods and
analyses on metabolic profiling GC-MS (153 plasma
metabolites), multiplex proteome analysis by Rules-
Based Medicine Inc. (79 plasma proteins), and clinical
chemistry measurements (7 parameters), have been pre-
viously described [14, 24]. In the context of this manu-
script, additional in-depth proteomics was performed
using the SOMAscan® platform (1150 proteins, SomaLo-
gic Inc.). In addition, vitamin and carotenoid concentra-
tions have been determined as described below.
Proteomics
In addition to the previously applied Rules-Based Medi-
cine platform, in-depth proteomics analysis using
SOMAscan technology was performed on all EDTA
plasma samples. Plasma samples (65 μl) were analyzedon the SOMAscan Version 3 assay, which measures
1150 proteins simultaneously using novel modified DNA
aptamers called SOMAmer® reagents to specifically bind
protein targets in biologic samples [25–27]. Each sample
in this study was normalized by aligning the median of
each sample to a common reference. Inter-plate calibra-
tion was done by applying a multiplicative scaling coeffi-
cient to each SOMAmer reagent. These scaling factors
were calculated using the eight reference calibrators on
each plate.
Vitamin and carotenoid analysis
For all analyses, EDTA plasma has been used. The
levels of 25-hydroxyvitamin D3 have been analyzed by
HPLC-MS/MS using a modified, previously published
stable isotope dilution assay [28]. In brief, proteins
were removed from the plasma with the double vol-
ume of acetonitrile, which contained deuterated 25-
hydroxyvitamin D3 as internal standard. After centrifu-
gation, an aliquot of the supernatant was injected into
the HPLC system. Detection of specific mass transi-
tions (MRM mode) of the analyte and internal stand-
ard using a triple quadrupole detector (LC/MS/MS)
with an atmospheric pressure photo ionization (APPI)
source was used for quantification. Levels of retinol
and tocopherols have been analyzed using HPLC with
fluorescence detection, whereas carotenoids were detected
in the same chromatographic run by Vis-detection [29]. In
brief, plasma proteins were precipitated with ethanol.
Carotenoids, retinol, and tocopherols were extracted
from the aqueous suspension with -hexane/BHT. After
centrifugation, an aliquot of the organic phase was
dried, re-dissolved, and injected onto a reversed-phase
(C18) HPLC system.
Data analysis
All previously and newly generated data were integrated
and correlated to concentrations for each of the eight
individual micronutrients. Correlation analysis was
performed using non-parametric Spearman’s rank cor-
relation test in order to prevent from focusing on out-
liers. For correlations at fasting, we selected to present
only those significant correlations (p value <0.05) with
correlation coefficients >|0.5| in order to focus on
moderate to strong correlations that were considered
most relevant. We used the correlations with coeffi-
cients between |0.4| and |0.5| as supporting data for
interpretation of the >|0.5| results. To substantiate the
identified correlations at fasting, ANOVA analysis was
performed to determine differences between low,
medium, and high micronutrient concentration groups.
For this, the 25th and 75th percentiles were calculated
for each compound. A value below or equal to its 25th
percentile was defined as group 1, values between the
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a value higher or equal to the 75th percentile was de-
fined as group 3. This resulted in a group assignment
for each individual value (groups 1, 2, and 3) for each
micronutrient. A one-way ANOVA was applied on the
fused data set with micronutrient group as fixed factor.
Since eight micronutrients were involved, eight differ-
ent group assignments were available. So, a one-way
ANOVA was applied eight times. Diagnostics, such as
a Levene test to test the equality of variances of the re-
siduals and assessing the normality of residuals (skew-
ness, normality, and kurtosis or flat relative to a
normal distribution), were used to check if the
ANOVA assumptions were valid. If the ANOVA as-
sumptions were not met, the corresponding variable
was LOG transformed and the ANOVA analysis was
repeated. The ANOVA assumptions were checked
again using diagnostics. The null hypothesis (no effect
of micronutrient group) was rejected at the 0.05 level
of significance.
The SOMAscan analytes measured in response to the
NCT were analyzed using a mixed model on time ef-
fects. Data was LOG transformed to meet the ANOVA
assumptions. FDR correction was used to correct for
multiple testing. For parameters with a significant time
effect (p < 0.05) in response to the NCT, incremental
areas under the curve (AUC) were calculated using the
first measurement (t0) as reference. We determined both
AUC positive relative to baseline (AUCp) and AUC
negative relative to baseline (AUCn). For previously gen-
erated data, Bakker et al. [24] reported on statistical ana-
lysis of GC-MS and protein profiling data using two-way
ANOVA. Here, we selected those parameters with a sig-
nificant time effect. Per parameter either AUCp or
AUCn values were selected for further correlation ana-
lysis, based on the largest average.
For correlations in response to NCT, we selected to
present only those significant correlations (p value <0.05)
with correlation coefficients for AUCs > |0.4| in order to
focus on strong and moderate correlations that were being
considered as being most relevant.
Correlation networks were created visualizing all sig-
nificant and relevant parameters with coefficients above
the abovementioned threshold connected to micronu-
trient nodes using their respective correlations as edges,
using Cytoscape software (http://www.cytoscape.org/) [30].
Results
To assess the influence of micronutrient status on pro-
cesses relevant to health, we determined the plasma
concentrations of retinol, the carotenoids α-carotene,
β-carotene, β-cryptoxanthin, and lycopene, α- and γ-
tocopherol, and 25-hydroxyvitamin D3 in a study popu-
lation of 36 overweight and obese males with mildlyelevated CRP levels. Demographic characteristics and
key laboratory values of subjects have been reported
previously [24]. Correlation analyses were performed to
identify the links between micronutrient status and a
total of 1389 variables based on clinical chemistry (n =
7), metabolomics (n = 153), 79 plasma proteins, and the
newly quantified proteins via SOMAscan (n = 1150, of
which n = 54 overlapped with RBM platform) at baseline
and in response to NCT. Finally, we investigated the
representation of pathways and processes by the plasma
parameters that were correlated with one or more
micronutrients.
Vitamin and carotenoid status
Plasma concentrations of the fat-soluble vitamins retinol,
α- and γ-tocopherol, and 25-hydroxyvitamin D3, and the
carotenoids α-carotene, β-carotene, β-cryptoxanthin and
lycopene, were assessed at fasting (t = 0 min), i.e., before
the NCT was applied. The results, as summarized in
Table 1, indicate that the study subjects in general have
micronutrient statuses within ranges that have been re-
ported in similar studies in Western (male) populations
[31–33]. To establish coherence between the eight
micronutrients assessed, Spearman correlation analysis
was performed on all micronutrient data (Additional file
2: Table S2). This revealed relatively strong correlation
between α-tocopherol and retinol status and to a lesser
extent between α- and γ-tocopherol status (Fig. 1a, b).
Plasma concentrations of the other fat-soluble vitamins
and carotenoids did not correlate strongly.
Micronutrient status correlation network at fasting
To identify molecular processes and pathways that may
be directly or indirectly influenced by status of the eight
micronutrients selected, we performed correlation ana-
lyses on the 1389 variables quantified at fasting in this
study.
The Spearman correlation coefficients were found to
range between −0.681 and 0.685. The distribution of r’s
was similar for all micronutrients. Only limited numbers
of correlation coefficients larger than |0.5| were ob-
served, ranging from 3 (out of 1389 variables) for both
carotenes to 17 for α-tocopherol. The correlation net-
work based on all individual variables with coefficients
larger than |0.5| with any of the micronutrients is visual-
ized (Fig. 2). For some of the strongest micronutrient
correlations, confirmation of the relevance of the ob-
served correlations was obtained by ANOVA analyses
for differences between the lowest and highest quartile
in micronutrient status, illustrating the validity of the
observed correlations (Additional file 3: Figure S1).
In-depth analyses of the correlations per individual
micronutrient showed that only a small proportion of
the variables overlap between the micronutrients (Fig. 2)
Table 1 Plasma vitamin and carotenoid concentrations in 36 overweight men with mildly elevated plasma CRP levels
Vitamin or carotenoid Plasma concentration (Mean ± SEM) Range Number < LOQ (<LOD) Reference ranges
Retinol (μM) 1.97 ± 0.05 1.29–2.60 Na 1.19–2.24c [31]
γ-Tocopherol (μM) 1.74 ± 0.11 0.73–3.94 Na 0.96–2.30c [31]
α-Tocopherol (μM) 29.0 ± 1.1 13.7–48.3 Na 12–46 [32]
β-Cryptoxanthin (μM) 0.22 ± 0.03 0.06–0.83 Na 0.14–0.40c [31]
Lycopene (μM) 0.62 ± 0.05 0.15–1.28 Na 0.54–0.73c [31]
α-Carotene (μM) 0.06 ± 0.01 <LOD–0.27 16/35 (2/35)a 0.07–0.12c [31]
β-Carotene (μM) 0.40 ± 0.03 0.12–0.83 Na 0.31–0.49c [31]
25-Hydroxy vitamin D3 (nM) 63.2 ± 5.6 <LOQ–128.8 4/34
b 20–136.2d [33]
aLOQ and LOD for α-carotene are 0.06 and 0.03 μM, respectively
bLOQ for 25-hydroxy vitamin D3 is 12.0 nM
cMean values from cohorts of healthy adults from five European countries
dMean population values
Fig. 1 Distribution of plasma concentrations for α-tocopherol vs retinol (a) and α-tocopherol vs γ-tocopherol (b) in 36 overweight and obese
males with mildly elevated CRP levels. Spearman correlation coefficients for both data sets are presented in the figures
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Fig. 2 Micronutrient correlation network visualizations of baseline in 36 overweight and obese men with mildly elevated CRP levels. Spearman correlation
analysis was performed with all data measured after overnight fasting. The network represent all correlations >|0.5| in connection to the micronutrient
nodes. The thickness of edges represents the strength of correlation, positive and negative correlations are presented as blue and red edges, respectively.
Node size reflects the degree of centrality in the network. Centrality is a measure of the connectedness of a network node; it therefore reflects how many
connects each node has to others. Activin A receptor type 1B (ACVR1B), aldo-keto reductase family 1, member A1 (AKR1A1), alanine aminotransferase
(ALT), apolipoprotein C3 (APOC3), apolipoprotein H (APOH), ATP synthase H+ transporting mitochondrial F1 complex beta polypeptide (ATP5B), bone
morphogenetic protein 1 (BMP1), stearic acid (C18:0), vaccenic acid (C18:1), complement C1r subcomponent (C1R), complement component (C3), CD40
molecule (CD40), checkpoint kinase 1 (CHEK1), chemokine cxc motif ligand 8 (CXCL8), diglyceride (DG), family with sequence similarity 107 member 8
(DRR1), ephrin A5 (EFNA5), estrogen receptor 1 (ESR1), Fc receptor like 3 (FCRL3), homeostatic model assessment for insulin resistance (HOMA-IR), high
sensitivity c-reactive protein (hsCRP), interleukin 1 receptor type 1 (IL1R1), interleukin 20 receptor subunit alpha (IL20RA), interleukin 34 (IL34), interleukin
5 (IL5), kallikrein related peptidase 8 (KLK8), kallikrein related peptidase 11 (KLK11), keratin 18 (KRT18), layilin (LAYN), leptin receptor (LEPR), leukocyte
immunoglobulin like receptor B2 (LILRB2), leukotriene a4 hydrolase (LTA4H), mitogen activated protein kinase 11 (MAPK11), colony-stimulating factor 1
(macrophage) (M-CSF), matrix metallopeptidase 8 (MMP8), osteomodulin (OMD) plasminogen activator inhibitor 1 (PAI1), protein C (PROC), prostaglandin
endoperoxide synthase 2 (PTGS2), peptide YY (PYY), serpin family A member 6 (SERPINA6), SH2 domain containing 1A (SH2D1A), secretory leukocyte
peptidase inhibitor (SLPI), sortilin-related vps10 domain containing receptor 2 (SORCS2), tenascin C (TNC), tumor necrosis factor receptor superfamily
member 10d (TNFRSF10D), tumor necrosis factor receptor superfamily member 19 (TNFRSF19), topoisomerase (DNA) 1 (TOP1), vascular endothelial
growth factor A (VEGFA), X-ray repair complementing defective repair in Chinese hamster cell 6 (XRCC6)
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specific parameters. The correlations per micronu-
trient group, i.e., the carotenoids, the tocopherols,
and vitamin D, are described in more detail below,where parameters with significant (p < 0.05) correl-
ation coefficients between |0.4| and |0.5| used as
supporting data for biological interpretation are
shown in italic.
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Retinol (vitamin A) concentrations correlated positively
with a number of parameters from glucose and lipid
metabolism that are associated with metabolic disease,
including 4-deoxyglucose, plasma total free fatty acid
levels, total ketone bodies, and total cholesterol levels.
As expected, the products of several retinoic acid indu-
cible genes, i.e., matrix metalloproteinase 8 (MMP8)
and soluble leptin receptor (sLep-R) also correlated
positively with plasma retinol status. Inverse correla-
tions were observed for proteins reflecting inflamma-
tory processes, including complement subunits (C1r
[Additional file 3: Figure S1A], C4b, C5b), C-reactive
protein (CRP, Additional file 3: Figure S1B), and
leukocyte immunoglobulin-like receptor B2 (LILRB2), a
marker of tolerogenic dendritic cells, which are sug-
gestive of an immunosuppressive effect of vitamin A.
The correlation network of retinol showed large simi-
larities with processes that are associated with status of
the antioxidant vitamin E (α-tocopherol).Carotenoid correlations at fasting
The status of the 4 different carotenoids quantified, i.e.,
α- and β-carotene, β-cryptoxanthine, and lycopene,
showed largely differing correlation patterns at fasting
and only overlapped with retinol to a limited extent.
Plasma β-carotene concentrations correlated positively
with a number of cholesterol-related lipids, including
LDL cholesterol, lysophospatidylcholines (LPC), and
sphingomyelins (SM). In addition, sortilin-related VPS10
domain containing receptor 2 (SORC2), a recently iden-
tified neuropeptide receptor, G protein-coupled receptor
associated sorting protein 2 (GASP2), and interleukin 34
(IL-34) were among the strongest correlating proteins.
Inverse correlations were found for both systolic and
diastolic blood pressure levels (Additional file 3:
Figure S1G), which were highly β-carotene specific. In
addition, endothelial function markers plasminogen
activator inhibitor-1 (PAI-1, Additional file 3: Figure S1H),
von Willebrand Factor (vWF), and fibronectin all corre-
lated negatively with β-carotene concentrations. Together,
this suggests that β-carotene concentrations modulate
vascular health.
Plasma α-carotene concentrations correlated inversely
with a number of interleukin-1 (IL-1) associated pro-
teins, including IL-1b, IL-1R4, and IL-1R-accessory pro-
tein, the NF-kB activating protein TRAIL-R4, and livin,
as well as blood lymphocyte counts. Together with
several positively correlated factors including IL-34
(Additional file 3: Figure S1I), chemokine CCL1 (I-309),
IL-1sRI, and neutrophil counts, which are all involved in
inflammatory action, the results suggest an immuno-
modulatory role or effect for α-carotene.β-Cryptoxanthin plasma concentrations correlated
with a couple of key enzymes in the arachidonic acid
metabolic pathway, i.e., leukotriene A4 hydrolase
(LTHA4; inverse correlation), and prostaglandin H2
synthase 2 (PTGS2, alias COX-2; positive correlation),
suggesting a modulatory role in inflammatory eicosa-
noid production, which is further supported by the
inverse correlation with C-X-C motif chemokine
ligand 8 (CXCL8), and the positive correlation with
activated protein C (PROC). In addition, this caroten-
oid correlated inversely with liver function markers
alanine aminotransferase (ALT, Additional file 3:
Figure S1N) and γ-glutamyl transpeptidase (GGT)
and liver fibrosis associated marker Tenascin C
(TENC4 and TNC).
Similar to β-cryptoxanthin, lycopene concentrations
correlated positively with PTGS-2 (Additional file 3:
Figure S1K) and activated protein C (PROC). Lyco-
pene levels also correlated positively with a couple of
proteins involved in DNA replication and repair, such
as DNA repair protein XRCC6 (alias Ku70), check-
point kinase 1 (CHK1), and topoisomerase 1 (TOP1,
Additional file 3: Figure S1L). Interestingly, the con-
centrations of a large but specific group of triglycer-
ides (TG) were inversely correlated to lycopene
concentrations. These lipids comprised exclusively of
TG species with a carbon number between C40 and
C52 and lacking any of the TG species with higher
carbon numbers.Vitamin E (α-tocopherol only) correlations at fasting
As indicated above, the correlation network of α-
tocopherol showed large similarities with that of ret-
inol. Many lipid moieties, including total cholesterol
(Additional file 3: Figure S1C), lysophosphatidylcholines
(LPC), diglycerides (DG), and phosphatidylcholines
(PC), and associated proteins, e.g., apolipoprotein-CIII
(ApoCIII, Additional file 3: Figure S1D), were found to
correlate positively with baseline α-tocopherol levels.
Also, concentrations of CRP, C1r, LILRB2, and a
number of other inflammation associated molecules
correlated inversely with α-tocopherol. Unlike retinol,
moderate negative correlations with fasting insulin
levels and the derived homeostatic model assessment for
insulin resistance (HOMA-IR) index were observed in
the α-tocopherol network. Interestingly, these glucose
metabolism markers correlated stronger with the γ-
tocopherol plasma concentrations (e.g., HOMA-IR and
insulin, Additional file 3: Figure S1E). Accordingly,
negative correlations with insulin growth factor 1 (IGF-
1) and insulin growth factor binding protein 3 (IGFBP3)
as well as with glucose-associated carbohydrates ribose
and maltose were observed.
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γ-Tocopherol is the main form of vitamin E derived
from plant seeds. Compared to α-tocopherol, it exerts
different properties that may be important for human
health [34]. Triglycerides with medium to high carbon
number (C54-C56, Additional file 3: Figure S1F) corre-
lated positively with γ-tocopherol levels. In addition,
peptide YY (PYY), matrix metallopeptidase 3 (MMP3),
layilin, activin A receptor type 1B (ACVR1B), and inter-
leukin 1 receptor type 1 (IL1R1) showed relatively high
correlations with plasma levels of this vitamin, which
may all be linked to insulin sensitivity and associated
processes.
Vitamin D3 correlations at fasting
The parameters that correlated positively with fasting
25-hydroxyvitamin D3 plasma levels showed consider-
able overlap with parameters that had a positive correl-
ation to γ-tocopherol levels. The strongest correlations
were observed for kallikreins 8 and 11 (Additional file 3:
Figure S1O), IL-20 receptor antagonist (IL-20Ra),
secretory leukocyte protease inhibitor (SLPI), and
ephrin-A5. In addition, vitamin D levels correlated with
multiple sphingomyelins (SPMs), indicative of cell turn-
over and apoptosis. The parameters showing inverse cor-
relations were in general specific to vitamin D, with IL-3
and 5 (Additional file 3: Figure S1P), free fatty acid
C20:3 (C20:3-FFA), estrogen receptor (ER), SH2 domain
protein 1A (SH21A) and aldo-keto reductase family 1,
member A1 (AK1A1) being the top-ranked proteins. To-
gether, this data suggested a link of vitamin D3 levels
with inflammatory response and cell viability or
apoptosis.
Micronutrient status correlation network and phenotypic
flexibility
In order to assess the impact of the status of specific vi-
tamins and carotenoids on phenotypic flexibility as a
measure of health, we investigated the correlations of
plasma status with the response profiles during a NCT.
AUCs (either positive or negative) for all parameters that
were assessed during the postprandial response with a
significant time effect (418 out of 1389 parameters) were
correlated with fasting plasma concentrations of each of
the eight micronutrients analyzed. Similar to the result-
ing correlations at fasting, only limited numbers of sig-
nificant correlations with coefficients larger than |0.4|
were observed, showing correlation coefficients ranging
between −0.69 and 0.56. A total of 69 correlations
fulfilled the criteria, of which 14 with α-carotene, 6 with
β-carotene, 4 with cryptoxanthin, 7 with γ-tocopherol, 5
with lycopene, 16 with vitamin A, 11 with vitamin D3,
and 6 with vitamin E, as visualized in Fig. 3. To our
knowledge, many of the parameters in this network havenot been associated with any of these micronutrients be-
fore, possibly explained by the lack of similar studies in-
vestigating the link between vitamins, carotenoids, and
nutritional challenge test responses. This is also shown
in the fact that there were only nine overlapping correla-
tions with specific metabolites or proteins from the
micronutrient response network at fasting. Thus, the
micronutrients each generate a nearly complete and
unique postprandial response.
Most correlations were found for vitamin A. Lipid me-
tabolism associated parameters such as non-esterified
fatty acids (FFA), total free fatty acids (FA), and the fatty
acid C16:0 (C16:0), which all showed a positive response
to the NCT (AUC+), were inversely correlated to vita-
min A status. This indicates that a higher retinol status
is associated with a lower continuous increase in plasma
FFA concentrations after an initial lag phase of around
2 h to the NCT. Furthermore, free fatty acid C18:1
(C18:1), inositol and myo-inositol known to be involved
in phospholipid metabolism and apolipoprotein-A1
(ApoA1) associated with levels of HDL cholesterol, all
showed a negative response to the NCT (AUCs were in-
versely correlated to retinol status). So, a higher vitamin
A status is associated with a decreased negative response
to the NCT of these lipid metabolism associated param-
eters. Positive correlations of vitamin A and also α-
carotene and vitamin D3 status to chemokine cxc motif
ligand 11 (CXCL11) and complement C1r subcompo-
nent (C1R) both with AUC, suggest a larger decrease of
these inflammatory parameters in response to the nutri-
ent bolus in the case of higher micronutrient
concentrations.
α-Carotene shows in general inverse correlations to
the measured metabolites and/or proteins as correlation
is negative in 11 out of 14 parameters. The response of
the most of the parameters is positive upon NCT, as 11
out of 14 parameters showed an AUC increase (red dot,
AUC+). This means in general that higher levels of α-
carotene are associated with a reduced amplitude of
these parameters in response to the NCT.
Saturated free fatty acids C17:0 and C18:0 are in-
creased in response to the NCT as well as 4-methyl-2-
oxovaleric acid (promotes insulin secretion from β-cells),
4-deoxyglucose, and the enzymes alkaline phosphatase
(ALPL), inosine 5′-monophosphate dehydrogenase 1
(IMPDH1) all showed this inverse correlation, indicating
that higher levels of α-carotene are associated with a re-
duced amplitude of these parameters in response to the
NCT. Furthermore, protein levels of chymase 1 (CMA1)
and the anti-inflammatory proteins interferon lambda
1 (IFNL1), annexin A1 (ANXA1), and bactericidal
permeability-increasing protein (BPI), which is a lipopoly-
saccharide binding protein, further suggest an immuno-
modulatory role for α-carotene. Finally, albumin (ALB)
Fig. 3 Micronutrient correlation network visualizations of NCT response in 36 overweight and obese men with mildly elevated CRP levels. Spearman
correlation analysis was performed with all data measured with micronutrient AUCp or AUCn response data, i.e., NCT response. The networks represent all
correlations >|0.4| in connection to the micronutrient nodes (AUCp= blue node, AUCn= red node). The thickness of edges represents the strength of
correlation, positive and negative correlations are presented as blue and red edges, respectively. Node size reflects the degree of centrality in the network.
Centrality is a measure of the connectedness of a network node, it therefore reflects how many connects each node has to others. Albumin (ALB), alkaline
phosphatase, liver/bone/kidney (ALPL), annexin A1 (ANXA1), apolipoprotein A1 (APOA1), N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2
(ASAH2), bone morphogenetic protein 7 (BMP7), bactericidal/permeability-increasing protein (BPI), palmitic acid (C16:0), margaric acid (C17:0), stearic acid
(C18:0), vaccinic acid (C18:1), complement C1r subcomponent (C1R), complement component 3 (C3), C-C motif chemokine ligand 4 (CCL4), C-C motif
chemokine ligand 25 (CCL25), CD33 molecule (CD33), creatine kinase m-type (CKM), chymase 1 (CMA1), collagen type VIII alpha 1 (COL8A1), chemokine
cxc motif ligand 11 (CXCL11), endothelial cell specific molecule 1 (ESM1), growth differentiation factor 11 (GFD11), GDNF family receptor alpha (GFRA1),
hydroxysteroid (17-beta) dehydrogenase 1 (HSD17B1), interferon lambda 1 (IFNL1), interleukin 8 (IL8), Inosine 5′ monophosphate dehydrogenase 1
(IMPDH1), inhibin beta A (INHBA), kallikrein related peptidase 13 (KLK13), matrix metallo peptidase 2 (MMP2) matrix metallo peptidase 16 (MMP16),
pescadillo ribosomal biogenesis factor 1 (PES1), protein C (PROC), proteasome 26S subunit, non-ATPase 7 (PSMD7), pleiotrophin (PTN), peptide YY (PYY),
serpin family E member 1 (SERPINE1), structure specific recognition protein 1 (SSSRP1), tumor necrosis factor receptor superfamily member 1b (TNFRSF1B),
thyroid stimulating hormone beta (TSHB), thymic stromal lymphopoietin (TSLP)
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negative response to the NCT, which both showed a posi-
tive correlation to α-carotene, meaning that higher levels
of α-carotene are associated with a larger reduction of
these proteins in response to the NCT.In contrast, vitamin D3 is the only micronutrient
which showed almost complete positive correlations
with all its associated parameters except for interleukin-
8 (IL8) and thyroid-stimulating hormone beta (TSHB),
suggesting that vitamin D3 is associated with enhanced
van den Broek et al. Genes & Nutrition  (2017) 12:5 Page 10 of 14responses (both negative as well as positive) to the NCT.
Reduced vitamin D3 serum levels are known to be asso-
ciated with low-grade inflammatory health states such as
obesity. Here, we observed an inverse correlation of
vitamin D3 with IL8 suggesting that subjects with
higher levels of vitamin D3 status have a reduced pro-
inflammatory response upon NCT. Vitamin D3 levels
are also associated with increased response of gut hor-
mone peptide YY (PYY), which is indicative for a higher
appetite reduction upon the NCT. Furthermore, factors
that play a role in impairment of adipogenesis in
T2DM such as matrix metallopeptidase 2 (MMP2),
tumor necrosis factor receptor superfamily member 1B
(TNFRSF1B), and chemokine cxc motif ligand 11
(CXCL11), which all showed reduced levels in response
to NCT, showed an enhanced reduction in persons with
higher vitamin D3 levels.
Micronutrient status of vitamin D3 linked to β-
carotene via 3-methylhistidine, a marker for muscle pro-
tein catabolism, showed increased levels in response to
NCT and was observed to have a positive association to
both micronutrients. Additionally, β-carotene is also
positively associated with enhanced reduced response of
metabolite 1,5-anhydroglucitol and of proteins SER-
PINE1 (PAI-1) and pleiotrophin (PTN) which are all
linked to obesity and T2DM.
On the other side of the network, vitamin D3 is linked
to cryptoxanthin. Both micronutrients have a similar
positive correlation with AUCn of glutamic acid in re-
sponse to NCT. Markers CD3 and complement C3
showed reduced concentrations in response to NCT in
combination with a negative correlation, indicating that
higher levels of cryptoxanthin are associated with a de-
crease of these immune modulating markers in response
to NCT.
Vitamin E (α-tocopherol) and also γ-tocopherol are
both inversely correlated to the response of all associ-
ated metabolites and proteins, indicating that levels of
both tocopherols reduce the NCT response. Upon ad-
ministration of the NCT, four of the α-tocopherol asso-
ciated proteins showed increased concentrations, which
were pescadillo ribosomal biogenesis factor 1 (PES1) and
proteasome 26S subunit, non-ATPase, 7 (PSMD7),
protein c (PROC), and matrix metallopeptidase 16
(MMP16), which all have a proteolytic function.
γ-tocopherol is linked to α-tocopherol and also to vita-
min A and vitamin D3 via an inverse association to
thyroid-stimulating hormone beta (TSHB). Furthermore,
levels of γ-tocopherol are associated with a reduced
negative response of the proteins bone morphogenetic
protein 7 (BMP7), inhibin beta A (INHBA), collagen
type VIII alpha 1 (COL8A1), and GDNF family receptor
alpha 1 (GFRA1) which are all related to tumor growth
factor (TGFβ) that play a role in glucose toleranceregulation. Similar associations have also been observed
for kallikrein-related peptidase 13 (KLK13) and C-C
motif chemokine ligand 25 (CCL25).
Lycopene shares 2 associations with vitamin E (PROC
and CKM) and 1 association with vitamin A (GDF11).
The positive response of macrophage inflammatory pro-
tein (CCL4) upon NCT is exclusively correlated to lyco-
pene levels. The inverse relation to the micronutrient
suggests anti-inflammatory properties for lycopene.
Discussion
In view of the newly proposed definition of health [10],
emphasizing the individual’s ability to adapt to daily life
stressors such as excess nutrition, it is of importance to
understand the impact of various components influen-
cing physiology in homeostasis and other relevant chal-
lenges. Many studies, including those in nutrigenomics,
have been performed with a large variety of nutritional
challenges to establish the challenge response character-
istics in subjects with differential health states as de-
scribed extensively in a recent review by Dijk-Stroeve
[16]. However, this study is the first to assess phenotypic
flexibility as measured by nutritional challenge responses
in the context of plasma micronutrient status, as well as
the first to describe the micronutrient interaction net-
work in homeostasis. We investigated the micronutrient
correlation networks in a population of overweight and
obese men with mildly elevated plasma CRP levels, indi-
cative of low-grade chronic inflammation, to establish
that multiple micronutrients are related to multiple
health-related processes that maintain homeostasis and
phenotypic flexibility.
Our study population was relatively healthy with re-
spect to their micronutrient statuses; the plasma concen-
trations of all micronutrients, except for vitamin D, were
within proposed ranges of sufficiency based on defined
cut-offs or previously reported ranges in the general
population [31–33]. We did not find any subjects to be
overtly deficient for vitamin E, based on the cut-off
value for deficiency in healthy adults (12.0 μM) as pro-
posed by the Institute of Medicine [35] or due to a low
ratio of serum α-tocopherol to lipids (<0.8 mg/g total
lipids), as well as for retinol, based on a deficiency cut-
off value of 0.7 μM. Although the average 25-
hydroxyvitamin D status (63.22 ± 5.55 nM) indicates that
this study population is sufficient, over 30% of the sub-
jects were below 50 nM, suggesting insufficiency to defi-
ciency for this vitamin [36]. This is in line with a
systematic review, which reported 37.3% of the general
population to be insufficient and 6.7% to be deficient for
vitamin D [33]. For the carotenoids and γ-tocopherol,
the levels observed reflected those previously reported in
general population [31, 32]. Even though the study popu-
lation was in general sufficient for most micronutrients,
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sufficient to provide relevant outputs of correlation
analyses. The results showed a strong correlation be-
tween retinol and α-tocopherol status in the study
population, which may be explained by functional inter-
action. The oxidized α-tocopheroxyl radicals produced
are recycled back to the active reduced form through
reduction by other antioxidants, such as retinol [37], al-
though its significance in vivo has been debated [38].
Alternatively, the correlation may simply be explained
by dietary co-occurrence or joint transport lipid parti-
cles. Our analyses returned only a relatively small num-
ber of correlations of relevance. Although this may
suggest limited interaction, this could actually reflect
the relatively normal plasma micronutrient levels in the
study subjects. As it may be expected that the impact
of micronutrients on various processes and challenge
response is small within these normal ranges, many
correlations could be masked by the small study size.
At the same time, this also emphasizes the strength of
the correlations that were observed within this small
data set.
In-depth analysis of the correlation network at fasting
revealed several correlations that have not been ad-
dressed in the past. In a proteomics study of micronu-
trient status in undernourished Nepalese children, Cole
et al. [7] described proteins that correlated well with ret-
inol, α-tocopherol, and vitamin D3. In that population,
retinol status correlated with retinol-binding protein 4
(RBP4) and complement C1r, a protease involved in ini-
tiating the classical complement cascade [39]. Remark-
ably, whereas the negative correlation with the latter
(Additional file 3: Figure S1A) was also observed in our
study, no correlation of RBP4 (r = 0.034) with retinol sta-
tus was observed. This may be explained by the relative
adequate retinol levels of our study population as com-
pared to the undernourished Nepalese children (2.00 ±
0.3 μM vs 1.04 ± 0.27 μM) not representing a concentra-
tion range in which RBP4 is strongly correlated. The
negative correlation between retinol status and CRP
levels (Additional file 3: Figure S1B) has also been
reported before [40, 41]. Together with the other pro-
teins, these markers support the well-established reported
immunosuppressive/anti-inflammatory and immuno-
modulatory effects of retinol [42]. The relatively strong
correlation of specifically β-carotene with blood pres-
sure (Additional file 3: Figure S1G) has been well estab-
lished. Higher β-carotene plasma concentrations have
been associated with lower systolic and diastolic blood
pressure levels in several cross-sectional studies on car-
diovascular risk [43–45]. Although the mechanisms are
still unclear, the antioxidant function of this carotenoid
may impact endothelial health and as such, vascular
flexibility. Vitamin E, specifically α-tocopherol, has nospecific plasma carrier protein but is primarily associ-
ated with low to intermediate density lipoproteins for
transport [46]. As expected, positive correlations were
found between α-tocopherol status and total cholesterol
levels (Additional file 3: Figure S1C), which is the
principle component of VLDL [47] and ApoCIII (Add-
itional file 3: Figure S1D), which is the principle com-
ponent of VLDL [47], one of the first apolipoproteins
to be released with vitamin E from the liver [48] was
also identified in our study. Other potential biomarkers
derived from the Nepalese children cohort, i.e., RGS8 as
biomarker for α-tocopherol, and vitamin D binding protein
(VDBP) together with Plexin-D1 for vitamin D, were not
included in our targeted proteomics platforms. The correl-
ation network of α-tocopherol and retinol showed similarity
both in the lipid moieties and in the inflammatory parame-
ters. Although we cannot rule out a partially similar role in
processes driving these parameters, the overlap may be a
representation of the correlation in plasma levels observed,
which has been reported previously [49]. This may be the
result of a potentially linked joined transport in association
with lipid particles. Finally, the positive correlation we ob-
served between lycopene status and DNA repair protein
subunit Ku70 has been previously reported in a study de-
scribing the protective effect of lycopene on oxidative
stress-induced cell death pancreatic acinar cells [50]. This
may be part of the antioxidant function of this carotenoid
related to ameliorating oxidative stress-induced DNA dam-
age. Taken together, these findings provided confidence in
our findings to confirm the expected associations.
Whereas the correlation network at fasting was rather
evenly distributed in a number of relatively strong corre-
lations per micronutrient, the network for the NCT re-
sponses was rather skewed towards γ-tocopherol and
especially α-carotene besides the similar vitamin A re-
sponse (Fig. 3), suggesting a more prominent role for
these micronutrients in the maintenance of the pheno-
typic flexibility machinery. Only two parameters (inositol
and C18:1) which were correlated to vitamin A showed
an identical correlation measured at fasting and in re-
sponse to NCT. In both situations, vitamin A plays a sig-
nificant role as it has the most (NCT) or second most
(at fasting) correlations. Cryptoxanthin and vitamin E
showed a large number of correlations in the fasting
state, while the number of correlations at least halved in
response to the NCT. This is in contrast to α-carotene
that only showed three correlations at fasting conditions
while this almost quintupled in response to the NTC.
This study shows that applying the challenge test con-
cept is able to reveal previously unidentified correlations
between specific micronutrients and health-related pro-
cesses, with potential relevance for health maintenance
indicators that were not observed by correlating mea-
surements at fasting.
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in view of its reported beneficial effects on aging and
cardiovascular disease development risk [3]. Lycopene is
reported to eliminate reactive oxygen species (ROS), in-
hibits lipid peroxidation, and reinforces the immune sys-
tem. In our study, we observed in homeostatic
conditions that lycopene plasma concentrations mainly
overlap with other micronutrients. However, its only
unique inverse correlation with C-C motif chemokine
ligand 4 (CCL4) relates to the protective effect of lyco-
pene on oxidative stress-induced cellular damage and
implicates a potential role in chemoprotection in cancer
or other diseases [50, 51]. Recently, higher serum con-
centrations of lycopene have been associated with higher
survival time among participants with metabolic syn-
drome [52].
In contrast to lycopene, γ-tocopherol has received only
limited attention in relation to health benefits. Most of
the vitamin E research has focused on α-tocopherol as it
has been stated that this is the only considered form of
active vitamin E by EFSA [53] and due to its presumed
higher biological antioxidant activity [54], even though
several studies have indicated that only γ-tocopherol and
not α-tocopherol plasma levels were biomarkers for can-
cer and cardiovascular disease risk [55]. However, the to-
copherols exert different anti-inflammatory [56, 57] and
antioxidative properties [54], potentially necessitating a
reconsideration of their respective impact on health and
disease. One of the interesting findings in our study is
that in response to the NCT, higher plasma γ-tocopherol
concentrations correlate with ameliorated inflammatory
response as reflected by reduced responses of pro-
inflammatory chemokines and family members and li-
gands of the tumor necrosis factor receptor superfamily
(TNFRSF) (BMP7, INHBA, COL8A1, and GFRA1). This
may be of interest especially in view of the study popula-
tion being overweight and obese men with low-grade in-
flammation who may have an elevated risk for
development of type 2 diabetes (T2DM) and complica-
tions thereof such as cardiovascular disease and micro-
vascular complications in kidney, eye, and extremities.
Vitamin status and vitamin supplement interventions
have received considerable attention in the field of
T2DM [58, 59]. Low status of the antioxidants (vitamin
A, C, and E) as well as low status of the B vitamins has
been described in T2DM patients and is linked to in-
creased risk of developing T2DM. Furthermore, clinical
studies with vitamin E supplements in the form of α-
tocopherol have resulted in varying outcomes.
Interestingly, we observed a specific overlap in regula-
tion of thyroid-stimulating hormone beta (TSHB) by
vitamin A, vitamin D3, and γ-tocopherol. For vitamin A
(in rats) and D3 (in human), it has been shown that there
is an association between low serum levels and highthyrotropin (TSH) concentrations [60, 61]. This is con-
sistent with the possibility that vitamin A deficiency sup-
presses activation of pituitary retinoid receptor, thereby
increasing TSHB mRNA transcription which leads to
high TSH secretion [62]. For γ-tocopherol, there is no
direct evidence of a relationship with thyroid-stimulating
hormone (TSH). Thyroid hormones play an important
role in regulating energy metabolism and thereby body-
weight and adipose tissue homeostasis and eventually in-
sulin resistance. Therefore, their serum levels have been
associated with cardiovascular risk factors in overweight
and obese adolescents [63].
Conclusions
Although this study is an observational study, it has re-
sulted in a number of insights in the biological roles and
importance of the eight micronutrients studied in homeo-
stasis and more importantly in health with regard to pheno-
typic flexibility. Many of the correlations and expected
observations could be confirmed in our study, providing
confidence in the systems biology approach that was used.
Interestingly, new insights of potential roles of micronutri-
ents in health were found especially in response to a nutri-
tional challenge test. Many of these correlations may only
become clear when challenging the biological system as we
did using the NCT. In the current study, we focused on the
interpretation of the role of the isolated micronutrients. A
next step would be to also consider multi-micronutrient
interaction networks and its impact on health in which the
current study limitations are taken into consideration such
as genetics, where many single nucleotide polymorphisms
can be linked to carotenoid metabolism. For example, lyco-
pene bioavailability is associated with 28 single nucleotide
polymorphisms (SNPs) in 16 genes [64] and also food in-
take analysis (markers) for a better understanding of high
inter-individual variability in responses. Future epidemio-
logical and intervention research building upon these
insights by applying systems biology concepts, more exten-
sive multi-nutrient analyses, and nutritional challenge tests
will help to produce more efficient and potentially person-
alized micronutrient supplementation programs.
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